Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

AZAHAR Study. Observational Retrospective Study To Describe Characteristics And Clinical Outcomes of Patients With Systemic Lupus Erythematosus Initiating Saphnelo (Anifrolumab) in a Real-World Setting

NCT06626945 is registered in ClinicalTrials.gov with AstraZeneca as lead sponsor.

NCT NCT06626945
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06626945 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
AZAHAR Study. Observational Retrospective Study To Describe Characteristics And Clinical Outcomes of Patients With Systemic Lupus Erythematosus Initiating Saphnelo (Anifrolumab) in a Real-World Setting
Lead sponsor
AstraZeneca
Phase
Observational
Overall status
Completed
Start date
February 3, 2025
Completion date
June 5, 2025
Enrollment
152 (actual)
Sites
13

Conditions

As the registry lists them; a condition with its own page is linked.

systemic lupus erythematosus (sle)